This report is a result of an on-site licensure renewal inspection conducted on September 18-19, 2014 by staff from the Division of Drug and Alcohol Program Licensure. Based on the findings of the on-site inspection, Pyramid Healthcare York Pharmacotherapy Services was found not to be in compliance with the applicable chapters of 28 PA Code which pertain to the facility.
This report is a result of an on-site licensure renewal inspection and for the approval to use a narcotic agent, specifically Methadone/Buprenorphine in the treatment of narcotic addiction. The inspection was conducted on Setempber 18-19, 2014 by staff from the Division of Drug and Alcohol Program Licensure. Based on the findings of the on-site inspection, Pyramid Healthcare York Pharmacotherapy Services was found not to be in compliance with the applicable chapters of 28 PA Code which pertain to the facility.
|
Plan of Correction
|
Observations
Based on a review of client records, the facility failed to obtain an informed and voluntary consent from the client in one of eighteen client records.
The findings include:
Eighteen client records were reviewed on September 18-19, 2014. All eighteen client records were required to include an informed and voluntary consent from the client prior to the disclosure of information. A consent to release was not obtained in record #10.
Client #10 was admitted to the outpatient level of care on January 21, 2014 and discharged on March 27, 2014. Several fax transmittals dated 2/4/14, 2/14/14, 2/18/14, 2/19/14 and 2/20/14 to the client's insurance company was reviewed on September 19, 2014. A release of information for the funding source was not obtained prior to disclosure.
These findings were reviewed with facility staff during the licensing process.
|
Plan of Correction
Proper consent will be signed by client by 10/13/2014. Moving forward all releases of information will be completed during the time of intake, and when a change occurs.
Staff will be retrained on this topic at the next staff meeting 10/16/2014 and compliance will be ensured through random monthly monitoring of clinical and medical charts completed by the Clinical Supervisor and/or the Program Director. |